P3 Health Partners (PIII) Capital Expenditures (2021 - 2025)

P3 Health Partners (PIII) has 5 years of Capital Expenditures data on file, last reported at -$198000.0 in Q4 2025.

• Quarterly Capital Expenditures fell 9800.0% year-over-year to -$198000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$79000.0 (changed N/A YoY) and the FY2025 annual result came in at -$79000.0, changed N/A from the prior year.
• Capital Expenditures advanced to -$198000.0 in Q4 2025, from -$14.3 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $14.3 million in Q1 2025 to a low of -$14.3 million in Q3 2025.
• A 5-year average of $257673.9 and a median of $39500.0 in 2024 frame the typical range for Capital Expenditures.
• The widest YoY moves for Capital Expenditures: up 84282.35% in 2025, down 23237.1% in 2025.
• Tracing PIII's Capital Expenditures over 5 years: stood at $1.1 million in 2021, then sank by 109.03% to -$100000.0 in 2022, then surged by 713.0% to $613000.0 in 2023, then plunged by 100.33% to -$2000.0 in 2024, then slumped by 9800.0% to -$198000.0 in 2025.
• The last three Capital Expenditures figures came in at -$198000.0 (Q4 2025), -$14.3 million (Q3 2025), and $119000.0 (Q2 2025), per Business Quant data.